Picture of Bioxyne logo

BXN Bioxyne Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Annual cashflow statement for Bioxyne, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2017
June 30th
2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.0610.2580.2280.0480.019
Other Operating Cash Flow
Cash from Operating Activities-0.424-1.86-1.390.0520.053
Capital Expenditures-0.004-0.171-0.064-0.0340
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0390-0.1090
Acquisition of Business
Sale of Business
Cash from Investing Activities0.035-0.171-0.172-0.0340
Financing Cash Flow Items-0.18500
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.91.350-0.052-0.047
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.52-0.566-1.54-0.02-0.146

Or unlock with your email

Or unlock with your email